Erratum: Establishment and applications of Epstein-Barr virus-based episomal vectors in human embryonic stem cells (Stem Cells (2006) 24, (1338-1347) DOI: 10.1634/stemcells.2005-0338);Establishment and applications of epstein-barr virus-based episomal vectors in human embryonic stem cells

Stem Cells

Volumn 24, Issue 5, 2006, Pages 1338-1347

  Ren, Caiping ^a   Zhao, Ming ^a   Yang, Xuyu ^a   Li, Dongsheng ^c   Jiang, Xingjun ^b   Wang, Lei ^a   Shan, Wenjiao ^a   Yang, Hong ^a   Zhou, Liang ^a   Zhou, Wen ^a   Zhang, Hongbo ^a  

^a Central South University   (China)

^b CENTRAL SOUTH UNIVERSITY   (China)

^c HUBEI UNIVERSITY OF MEDICINE   (China)

Author keywords

Episomal vectors; Epstein Barr virus replicon; Human embryonic stem cells; RNA interference; Stable gene transfer; Stable transgene expression

Indexed keywords

DNA FRAGMENT; ENHANCED GREEN FLUORESCENT PROTEIN; EPSTEIN BARR VIRUS ANTIGEN; HERPESVIRUS VECTOR; PLASMID DNA; PUROMYCIN; SHORT HAIRPIN RNA;

ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CELL PROLIFERATION; COMPARATIVE STUDY; CONTROLLED STUDY; DNA VECTOR; EMBRYONIC STEM CELL; EPISOME; EPSTEIN BARR VIRUS; EXPRESSION VECTOR; GENE CASSETTE; GENE EXPRESSION; GENE INSERTION; GENETIC TRANSFECTION; MOUSE; NONHUMAN; PROTEIN PROTEIN INTERACTION; RNA INTERFERENCE; RNA TRANSLATION; TRANSGENICS;

HUMAN HERPESVIRUS 4;

EID: 33748758591     PISSN: 10665099     EISSN: None     Source Type: Journal    
DOI: 10.1634/stemcells.2006-erratum.6     Document Type: Erratum

References (46)

1. Thomson JA, Itskovitz-Eldor J, Shapiro SS et al. Embryonic stem cell lines derived from human blastocysts. Science 1998;282:1145-1147.
2. Reubinoff BE, Pera MF, Fong CY et al. Embryonic stem cell lines from human blastocysts: Somatic differentiation in vitro. Nat Biotechnol 2000;18:399-404.
3. Pera MF, Reubinoff B, Trounson A. Human embryonic stem cells. J Cell Sci 2000;113:5-10.
4. Eiges R, Schuldiner M, Drukker M et al. Establishment of human embryonic stem cell-transfected clones carrying a marker for undifferentiated cells. Curr Biol 2001;11:514-518.
5. Zwaka TP, Thomson JA. Homologous recombination in human embryonic stem cells. Nat Biotechnol 2003;21:319-321.
6. Aubert J, Dunstan H, Chambers I et al. Functional gene screening in embryonic stem cells implicates Wnt antagonism in neural differentiation. Nat Biotechnol 2002;20:1240-1245.
7. Pfeifer A, Ikawa M, Dayn Y et al. Transgenesis by lentiviral vectors: Lack of gene silencing in mammalian embryonic stem cells and preimplantation embryos. Proc Natl Acad Sci U S A 2002;99:2140-2145.
8. Ma Y, Ramezani A, Lewis R et al. High-level sustained transgene expression in human embryonic stem cells using lentiviral vectors. STEM CELLS 2003;21:111-117.
9. Gropp M, Itsykson P, Singer O et al. Stable genetic modification of human embryonic stem cells by lentiviral vectors. Mol Ther 2003;7:281-287.
10. Margolskee RF, Kavathas P, Berg P. Epstein-Barr virus shuttle vector for stable episomal replication of cDNA expression libraries in human cells. Mol Cell Biol 1988;8:2837-2847.
11. Mazda O, Satoh E, Yasutomi K et al. Extremely efficient gene transfection into lympho-hematopoietic cell lines by Epstein-Barr virus-based vectors. J Immunol Methods 1997;204:143-151.
12. Cui FD, Kishida T, Ohashi S et al. Highly efficient gene transfer into murine liver achieved by intravenous administration of naked Epstein-Barr virus (EBV)-based plasmid vectors. Gene Ther 2001;8:1508-1513.
13. Nakanishi H, Mazda O, Satoh E et al. Nonviral genetic transfer of Fas ligand induced significant growth suppression and apoptotic tumor cell death in prostate cancer in vivo. Gene Ther 2003;10:434-442.
14. Zhang J, Wilson A, Alber S et al. Prolonged gene expression in mouse lung endothelial cells following transfection with Epstein-Barr virus-based episomal plasmid. Gene Ther 2003;10:822-826.
15. Sun TQ, Fernstermacher DA, Vos JM. Human artificial episomal chromosomes for cloning large DNA fragments in human cells. Nat Genet 1994;8:33-41.
16. Westphal EM, Sierakowska H, Livanos E et al. A system for shuttling 200-kb BAC/PAC clones into human cells: Stable extrachromosomal persistence and long-term ectopic gene activation. Hum Gene Ther 1998;9:1863-1873.
17. Wade-Martins R, Frampton J, James MR. Long-term stability of large insert genomic DNA episomal shuttle vectors in human cells. Nucleic Acids Res 1999;27:1674-1682.
18. Wade-Martins R, White RE, Kimura H et al. Stable correction of a genetic deficiency in human cells by an episome carrying a 115 kb genomic transgene. Nat Biotechnol 2000;18:1311-1314.
19. White RE, Wade-Martins R, James MR. Infectious delivery of 120-kilobase genomic DNA by an Epstein-Barr virus amplicon vector. Mol Ther 2002;5:427-435.
20. Adams A. Replication of latent Epstein-Barr virus genomes in Raji cells. J Virol 1987;61:1743-1746.
21. Yates JL, Guan N. Epstein-Barr virus-derived plasmids replicate only once per cell cycle and are not amplified after entry into cells. J Virol 1991;65:483-488.
22. Aiyar A, Tyree C, Sugden B. The plasmid replicon of EBV consists of multiple cis-acting elements that facilitate DNA synthesis by the cell and a viral maintenance element. EMBO J 1998;17:6394-6403.
23. Yates J, Warren N, Reisman D et al. A cis-acting element from the Epstein-Barr viral genome that permits stable replication of recombinant plasmids in latently infected cells. Proc Natl Acad Sci U S A 1984;81:3806-3810.
24. Yates JL, Warren N, Sugden B. Stable replication of plasmids derived from Epstein-Barr virus in various mammalian cells. Nature 1985;313:812-815.
25. Lee MA, Diamond ME, Yates JL. Genetic evidence that EBNA1 is needed for efficient, stable latent infection by Epstein-Barr virus. J Virol 1999;73:2974-2982.
26. Leight ER, Sugden B. EBNA1: A protein pivotal to latent infection by Epstein-Barr virus. Rev Med Virol 2000;10:83-100.
27. Längle-Rouault F, Patzel V, Benavente A et al. Up to 100-fold increase of apparent gene expression in the presence of Epstein-Barr virus oriP sequences and EBNA1: Implications of the nuclear import of plasmids. J Virol 1998;72:6181-6185.
28. Ramage AD, Clark AJ, Smith AG et al. Improved EBV-based shuttle vector system: dicistronic mRNA couples the synthesis of the Epstein-Barr nuclear antigen-1 protein to neomycin resistance. Gene 1997;197:83-89.
29. Amit M, Carpenter MK, Inokuma MS et al. Clonally derived human embryonic stem cell lines maintain pluripotency and proliferative potential for prolonged periods of culture. Dev Biol 2000;227:271-278.
30. Xu C, Inokuma MS, Denham J et al. Feeder-free growth of undifferentiated human embryonic stem cells. Nat Biotechnol 2001;19:971-974.
31. Xu R, Chen X, Li D et al. BMP4 initiates human embryonic stem cell differentiation to trophoblast. Nat Biotechnol 2002;20:1261-1264.
32. Tomiyasu K, Satoh E, Oda Y et al. Gene transfer in vitro and in vivo with Epstein-Barr virus-based episomal vector results in markedly high transient expression in rodent cells. Biochem Biophys Res Commun 1998;253:733-738.
33. Satoh E, Osawa M, Tomiyasu K et al. Efficient gene transduction by Epstein-Barr-virus-based vectors coupled with cationic liposome and HVJ-liposome. Biochem Biophys Res Commun 1997;238:795-799.
34. Sudgen B, Warren N. Plasmid origin of replication of Epstein-Barr virus, oriP, does not limit replication in cis. Mol Biol Med 1988;5:85-94.
35. Kirchmaier AL, Sugden B. Plasmid maintenance of derivatives of oriP of Epstein-Barr virus. J Virol 1995;69:1280-1283.
36. Margolskee RF. Epstein-Barr virus based expression vectors. Curr Top Microbiol Immunol 1992;158:67-95.
37. Lei DC, Kunzelmann K, Koslowsky T et al. Episomal expression of wild-type CFTR corrects cAMP-dependent chloride transport in respiratory epithelial cells. Gene Ther 1996;3:427-436.
38. Hirai H, Satoh E, Osawa M et al. Use of EBV-based vector/HVJ-liposome complex vector for targeted gene therapy of EBV-associated neoplasms. Biochem Biophys Res Commun 1997;241:112-118.
39. Kang M, Lu H, Yasui T et al. Epstein-Barr virus nuclear antigen 1 does not induce lymphoma in transgenic FVB mice. Proc Natl Acad Sci U S A 2005;102:820-825.
40. Ren CP, Zhao M, Shan WJ et al. Establishment of human embryonic stem cell line stably expressing Epstein-Barr virus-encoded nuclear antigen 1. Acta Biochim Biophys Sin 2005;37:68-73.
41. Black J, Vos JM. Establishment of an oriP/EBNA1-based episomal vector transcribing human genomic beta-globin in cultured murine fibroblasts. Gene Ther 2002;9:1447-1454.
42. Leight ER, Sugden B. Establishment of an oriP replicon is dependent upon an infrequent, epigenetic event. Mol Cell Biol 2001;21:4149-4161.
43. Wendelburg BJ, Vos JM. An enhanced EBNA1 variant with reduced IR3 domain for long-term episomal maintenance and transgene expression of oriP-based plasmids in human cells. Gene Ther 1998;5:1389-1399.
44. White RE, Wade-Martins R, James MR. Sequences adjacent to oriP improve the persistence of Epstein-Barr virus-based episomes in B cells. J Virol 2001;75:11249-11252.
45. Matin MM, Walsh JR, Gokhale PJ et al. Specific knockdown of Oct4 and β2-microglobulin expression by RNA interference in human embryonic stem cells and embryonic carcinoma cells. STEM CELLS 2004;22:659-668.
46. Zaehres H, Lensch MW, Daheron L et al. High-efficiency RNA interference in human embryonic stem cells. STEM CELLS 2005;23:299-305.